covid-19-india Archives | Future Medicine India


Baxter India gets CDSCO approval for Oxiris Filter Set use in critical COVID-19 patients

Baxter India said on Tuesday (08/07) that it has received approval from the Central Drugs Standard Control Organisation (CDSCO), India to use Oxiris Filter Set for the treatment of COVID-19 patients.

FM News Network
Read More..

India’s first COVID-19 vaccine receives DCGI nod for human trial

The Hyderabad-based biotechnology firm Bharat Biotech has received the nod from the Drug Controller General of India for conducting phase I and II human clinical trials for India’s first COVID -19 vaccine candidate, code-named as COVAXIN.

FM News Network

ICMR approves antigen-based test kit for detection of COVID-19

The Indian Council of Medical Research (ICMR) has recently approved a rapid antigen detection assay for the diagnosis of COVID-19 using nasal samples. Developed by SD Biosensor, Standard Q COVID-19 Ag detection kit is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2.

FM News Network

Niramai launches at-home screening service for breast cancer detection

An at-home breast cancer screening service has been launched by the Niramai Health Analytix in Bengaluru for helping assess breast health in women.

FM News Network

Plant-derived drug for COVID19 enters phase 2 clinical trial

The Indian multinational pharmaceutical company Sun Pharma has commenced a phase II clinical trial on the plant-derived drug AQCH to test its efficacy and safety in COVID-19 patients.

FM News Network

Tata Sons partners with Sree Chitra Tirunal Institute to make RT-LAMP based Covid-19 test kit

The Tata Group has entered into a partnership agreement with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, an institution of national importance, Department of Science and Technology, for commercial production of COVID-19 testing kits.

FM News Network

Glenmark to test efficacy of favipiravir and umifenovir combination against COVID-19

The Mumbai-based drug company Glenmark Pharmaceuticals is set to commence phase 3 clinical trial to test the combined efficacy of antiviral drugs favipiravir and umifenovir as a potential COVID-19 treatment strategy.

FM News Network